Phase I Study to Investigate Pharmacokinetics and Safety of BAY73-4506 in Asian (Japanese) Patients With Solid Tumors.
Clinical trial NCT00960258 · COMPLETED
Trial details
- NCT number
- NCT00960258
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2010-04-26
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.